United Therapeutics CEO trades 9,500 shares
United Therapeutics Chairperson & CEO Martine A. Rothblatt, through family trusts, exercised 9,500 stock options at $135.42 and acquired 9,500 common shares on July 27, 2026.
Rhea-AI Filing Summary
United Therapeutics Chairperson & CEO Martine A. Rothblatt, through family trusts, exercised 9,500 stock options at $135.42 and acquired 9,500 common shares on July 27, 2026. Those shares were then sold in multiple trades totaling 9,500 shares at prices between about $526 and $535 per share under a pre-arranged Rule 10b5-1 plan adopted November 7, 2025. Following the exercise, a trust reports 265,410 options remaining, as part of up to 1,734,410 options covered by the plan and expiring March 15, 2027, while separate entries show 40,513 shares held directly and 166 shares held indirectly by spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,500 shares ($3.75M approx. pre-tax spread)
Exercise and Sale
16 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
9,500 shs ($5.04M)
Approx. gross sale proceeds
$5.04M
Approx. exercise cost
$1.29M
Approx. pre-tax spread
$3.75M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F14 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $135.42 | $1.29M |
| Sale | Common Stock F1, F3, F2 | 680 | $525.8111 | $358K |
| Sale | Common Stock F1, F4, F2 | 890 | $527.1376 | $469K |
| Sale | Common Stock F1, F5, F2 | 650 | $528.507 | $344K |
| Sale | Common Stock F1, F6, F2 | 1,797 | $529.7493 | $952K |
| Sale | Common Stock F1, F7, F2 | 1,121 | $530.4861 | $595K |
| Sale | Common Stock F1, F8, F2 | 1,836 | $531.6488 | $976K |
| Sale | Common Stock F1, F9, F2 | 1,529 | $532.377 | $814K |
| Sale | Common Stock F1, F10, F2 | 957 | $533.5314 | $511K |
| Sale | Common Stock F1, F2 | 40 | $535.04 | $21K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F11 | -- | -- | -- |
| holding | Common Stock F12 | -- | -- | -- |
| holding | Common Stock F13 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 265,410 contracts (Indirect, by Trust);
Common Stock — 628,049 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (14)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $525.62 to $526.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $526.96 to $527.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $527.96 to $528.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $529.05 to $530.045. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $530.05 to $531.01 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $531.08 to $532.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $532.08 to $533.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F10. This transaction was executed in multiple trades at prices ranging from $533.13 to $534.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F12. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F13. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F14. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
Key Figures
Options exercised: 9,500 options
Shares sold: 9,500 shares
Example sale price: $525.8111 per share
+5 more
8 metrics
Options exercised
9,500 options
Stock options exercised on July 27, 2026 at $135.4200 per share
Shares sold
9,500 shares
Total common shares sold in multiple transactions on July 27, 2026
Example sale price
$525.8111 per share
Weighted average price for a 680-share sale tranche on July 27, 2026
Remaining options in trust
265,410 options
Stock options held by a family trust following the reported option exercise
Direct share holdings
40,513 shares
Common shares held directly by the reporting person as of July 27, 2026
Spouse indirect holdings
166 shares
Common shares held indirectly through the reporting person’s spouse
10b5-1 plan option capacity
1,734,410 options
Maximum stock options whose exercise is contemplated under the trading plan
10b5-1 plan latest end date
December 31, 2026
Latest termination date for the pre-arranged trading plan
Key Terms
Rule 10b5-1 trading plan, weighted average price, stock options, family trusts, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"transaction was executed in multiple trades at prices ranging from $525.62 to $526.36. The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
stock options financial
"exercise of 1,734,410 stock options, all of which expire on March 15, 2027"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
family trusts financial
"Shares held in family trusts as to which the Reporting Person shares investment power"
derivative security financial
"transaction code description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did United Therapeutics (UTHR) report for Martine A. Rothblatt?
On July 27, 2026, Chairperson & CEO Martine A. Rothblatt exercised 9,500 stock options at $135.42 into 9,500 common shares, then sold all 9,500 shares in multiple transactions executed through family trusts under a pre-arranged Rule 10b5-1 trading plan.
Was the UTHR CEO’s trading activity carried out under a Rule 10b5-1 plan?
Yes. The exercise of options and sale of resulting UTHR shares occurred under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025. The plan continues until the earlier of exercising 1,734,410 options or December 31, 2026.
How are family trusts involved in the UTHR insider transactions and holdings?
Both the option exercise and share sales were executed through family trusts. Footnotes state these trusts are entities where the reporting person or spouse shares investment power or serves as trustee, and the reporting person and/or immediate family members are beneficiaries of the trusts.
AI-generated analysis. How Rhea-AI works. Not financial advice.
